Compound heterozygosity for hemoglobin C and hemoglobin Korle-Bu

Laboratory Hematology

Volumn 14, Issue 4, 2008, Pages 30-34

  Kossover, Catherine L ^a   Eckman, James R ^a,b   Young, Andrew N ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY HEALTH SYSTEM   (United States)

Author keywords

Hemoglobin C; Hemoglobin Korle Bu; Hemoglobinopathy

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN C; HEMOGLOBIN KORLE BU; UNCLASSIFIED DRUG; HEMOGLOBIN KORLE; HEMOGLOBIN VARIANT;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; GLOBIN GENE; HEADACHE; HEMOGLOBINOPATHY; HEMOLYTIC ANEMIA; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; MICROCYTOSIS; NEGRO; SEQUENCE ANALYSIS; SHOULDER PAIN; DNA SEQUENCE; ELECTROPHORESIS; GENETICS; HETEROZYGOTE; MIDDLE AGED;

AFRICAN CONTINENTAL ANCESTRY GROUP; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS; FEMALE; HEMOGLOBIN C; HEMOGLOBINS, ABNORMAL; HETEROZYGOTE; HUMANS; MIDDLE AGED; SEQUENCE ANALYSIS, DNA;

EID: 59649119387     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.08001     Document Type: Article

References (15)

1. Hoyer JD, Kroft SH. Color Atlas of Hemoglobin Disorders. Northfield, IL: College of American Pathologists; 2003.
2. Vukelja SJ. Hemoglobin Korle-Bu (G-ACCRA) in combination with hemoglobin C. Am J Hematol. 1993;42:412.
3. Nagel RL, Lin MJ, Witkowska HE, Fabry ME, Bestak M, Hirsch RE. Compound heterozygosity for hemoglobin C and Korle-Bu: moderate microcytic hemolytic anemia and acceleration of crystal formation. Blood. 1993;82:1907-1912.
4. Vukelja S. Hemoglobin Korle-Bu (G-Accra) in combination with hemoglobin C [Abstract]. Blood. 1992;80:340a.
5. Hirsch RE, Lin MJ, Witkowska E, et al. Accelerated crystal formation in hemolysates from an infant with HbC/Korle-Bu hemoglobinopathy [Abstract]. Blood. 1990;76:62a.
6. Charache S, Conley CL, Waugh DF, Ugoretz RJ, Spurrell JR. Pathogenesis of hemolytic anemia in homozygous hemoglobin C disease. J Clin Invest. 1967;46:1795-1811.
7. Conley CL. Pathophysiological effects of some abnormal hemoglobins. Medicine (Baltimore). 1964;43:785-787.
8. Konotey-Ahulu FI, Gallo E, Lehmann H, Ringelhann B. Haemoglobin Korle-Bu (beta 73 aspartic acid replaced by asparagine) showing one of the two amino acid substitutions of haemoglobin C Harlem. J Med Genet. 1968;5:107-111.
9. Boi-Doku FS, Lehmann H, Beale D. Haemoglobin G-Accra. Nature. 1964;203:363-365.
10. Honig GR, Seeler RA, Shamsuddin M, Vida LN, Mompoint M, Valcourt E. Hemoglobin Korle Bu in a Mexican family. Hemoglobin. 1983;7:185-189.
11. Chico A, Padros A, Novials A. The Korle-Bu Hb variant in Caucasian women with type 1 diabetes: a pitfall in the assessment of diabetes control. Diabetes Care. 2004;27:2280-2281.
12. Ropero P, Villegas A, Gonzalez FA. Hemoglobin Korle-Bu [beta73(E17)Asp -> Asn]: first cases described in Spain [in Spanish]. Med Clin (Barc). 2004;123:260-261.
13. Adachi K, Asakura T. Polymerization of deoxyhemoglobin CHarlem (beta 6 Glu replaced by Val, beta 73 Asp replaced by Asn). The effect of beta 73 asparagine on the gelation and crystallization of hemoglobin. J Mol Biol. 1980;144:467-480.
14. Bookchin RM, Nagel RL, Ranney HM. Structure and properties of hemoglobin C-Harlem, a human hemoglobin variant with amino acid substitutions in 2 residues of the beta-polypeptide chain. J Biol Chem. 1967;242:248-255.
15. Forget BG, Higgs DR, Steinberg M, Nagel RL. Disorders of Hemoglobin: Genetic, Pathophysiology and Clinical Management. Cambridge, England: Cambridge University Press; 2001.